{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF00167",
      "entity_text" : "FGF",
      "entity_type" : "family"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0657" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "All the pathophysiological consequences of the abnormal high levels of FGF and the mechanisms involved in the generation of such excesses, summarized above, seem to provide a good rationale for an in vivo clinical trial aimed to explore whether dobesilate could be used to treat the abnormal angiogenesis and the subsequent epistaxis, associated with HHT.",
  "reading_complete" : "2020-08-02T13:11:14Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:08:51Z",
  "trigger" : "levels",
  "evidence" : [ "levels of FGF" ],
  "pmc_id" : "6660472",
  "score" : 0
}